Combinatorial chemistry company Chemicus focuses on bottlenecks in lead optimization in the drug discovery process. Chemicus claims that its abacus system makes larger amounts of similar compounds necessary for evaluating "hits" further down the drug discovery line.
You may also be interested in...
Progress for two US-based companies in the race to develop a COVID-19 vaccine.
MeMed has received CE Marking for its diagnostic test MeMed BV and point-of-need platform MeMed Key, which uses the human immune system to distinguish between bacterial and viral infections to prevent antibiotic overuse.
The latest global vaccines summit has seen the launch of a new mechanism designed to spur the development of new coronavirus vaccines and ensure they are made available, particularly in low- and middle-income countries.